Hospital General De Tomelloso — Clinical Trial Site

11 Registered trials

2 Currently recruiting

Organisation

Hospital General De Tomelloso

Location

Tomelloso, Spain

Identifier

ORG-100047461

Address

Vereda De Socuellamos S/n, 13700, Spain

Departments

Department of Gastroenterology
Digestive
Digestive Service
Digestivo
Gastroenterologist
Gastroenterology
Medicina Interna
Sección de Aparato Digestivo
Servicio de Gastroenterología y Hepatología

Clinical trials at this site (11)

Search interface

Long-term clinical trial on tolerability, toxicity, pharmacokinetics and molecular mechanisms of action of EPI-EE Pending

2025-520751-83-00 Eosinophilic Esophagitis as a archetype of chronic infl 3
A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3… Pending

2025-523674-16-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F… Pending

2025-523675-39-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting

2023-507853-13-00 Ulcerative Colitis 4 2025-02-25
Clinical study to demonstrate the same clinical efficacy and tolerability of budesonide orodispersible tablets (taken twice a day compared t… Recruiting

2024-515229-26-00 eosinophilic esophagitis 5 2021-05-21
A Study to Investigate the Efficacy and Safety of Solrikitug in Adults with Eosinophilic Esophagitis Ended

2024-510849-34-00 Eosinophilic Esophagitis 4 2025-02-04
A Phase 2a Study of Efinopegdutide in Adults With Compensated Cirrhosis Secondary to Metabolic Dysfunction-Associated Steatohepatitis Ended

2024-510923-20-00 Metabolic Dysfunction-Associated Steatohepatitis 4 2024-09-16
A clinical trial to evaluate efficacy, safety and cost-efficacy of gene analysis strategy in a population at risk of cardiovascular disease … Ended

2023-509418-12-00 Patients at risk of cardiovascular disease susceptible 6 2024-06-05
A study to investigate changes in symptoms and esophageal histology with tezepelumab compared with placebo in patients aged 12 to 80 years o… Ended

2023-504277-20-00 Eosinophilic esophagitis (EoE) is a rare, chronic infla 5 2023-01-30
A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic Steatohepatitis Ended

2022-502647-35-00 Non-alcoholic steatohepatitis 4 2023-09-01
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan… Ended

2024-513569-38-00 Crohn's Disease 10 2021-07-09